JEYCIO
Live / Applied — Fourth extension granted (statement of use) (as of 17 Jun 2025)
What this means for you
Not registered yet, but its 30 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97483429
- Mark type
- Stylized text
- Filed
- 30 Jun 2022
- Published for opposition
- 23 May 2023
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment atopic dermatitis, autoimmune diseases and disorders, Crohn's disease, dermatological diseases and disorders, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, inflammatory bowel disease, lupus, metabolic diseases and disorders, Psoriasis, Psoriatic arthritis, and ulcerative colitis
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 17 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2025 — SOU EXTENSION 4 GRANTED
- 17 Jun 2025 — SOU EXTENSION 4 FILED
- 17 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2024 — SOU EXTENSION 3 GRANTED
- 17 Dec 2024 — SOU EXTENSION 3 FILED
- 17 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jun 2024 — SOU EXTENSION 2 GRANTED
- 19 Jun 2024 — SOU EXTENSION 2 FILED
- 19 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 20 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Dec 2023 — SOU EXTENSION 1 GRANTED